Trials / Recruiting
RecruitingNCT01258231
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,000 (estimated)
- Sponsor
- Brigham and Women's Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.
Detailed description
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. In addition, we also examine blood and urine biomarkers (proteins).
Conditions
- Heart; Dysfunction Postoperative, Cardiac Surgery
- Genetic Predisposition to Disease
- Atrial Fibrillation
- Myocardial Infarction
- Heart Failure
Timeline
- Start date
- 2000-08-01
- Primary completion
- 2030-08-01
- Completion
- 2030-08-01
- First posted
- 2010-12-10
- Last updated
- 2024-08-22
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01258231. Inclusion in this directory is not an endorsement.